NEWPATHS Trademark
Trademark Overview
On Wednesday, June 14, 2023, a trademark application was filed for NEWPATHS with the United States Patent and Trademark Office. The USPTO has given the NEWPATHS trademark a serial number of 98041778. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 7, 2025. This trademark is owned by CSL Behring L.L.C.. The NEWPATHS trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
Providing medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
General Information
Serial Number | 98041778 |
Word Mark | NEWPATHS |
Filing Date | Wednesday, June 14, 2023 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Wednesday, May 7, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 2, 2024 |
Trademark Statements
Goods and Services | Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis |
Pseudo Mark | NEW PATHS |
Goods and Services | Providing medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis |
Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis |
Classification Information
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 18, 2023 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 18, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 18, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | CSL Behring L.L.C. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | King of Prussia, PA 19406 |
Party Name | CSL Behring L.L.C. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | King of Prussia, PA 19406 |
Trademark Events
Event Date | Event Description |
Tuesday, July 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 20, 2024 | ASSIGNED TO EXAMINER |
Monday, February 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, June 17, 2023 | NEW APPLICATION ENTERED |
Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, November 5, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, November 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, November 5, 2024 | SOU EXTENSION 1 FILED |
Tuesday, November 5, 2024 | SOU EXTENSION 1 GRANTED |
Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Wednesday, May 7, 2025 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 7, 2025 | SOU EXTENSION 2 FILED |
Wednesday, May 7, 2025 | SOU EXTENSION 2 GRANTED |
Wednesday, May 7, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |